Quarterly Statement of Operations Information (Unaudited) (Tables)

12 Months Ended

Sep. 26, 2015

Quarterly Financial Information Disclosure [Abstract]

Summary of Quarterly Results of Operations

The following table presents a summary of quarterly results of operations for fiscal 2015 and 2014:

	2015
	First Quarter		Second Quarter		Third Quarter		Fourth Quarter
Total revenue	$	652.8	$	655.5	$	693.9	$	702.8
Gross profit	338.6		336.0		378.7		379.4
Net income (1)	29.2		47.8		29.4		25.2
Diluted net income per common share	$	0.10	$	0.17	$	0.10	$	0.09

	2014
	First Quarter			Second Quarter			Third Quarter		Fourth Quarter
Total revenue	$	612.4		$	625.0		$	632.6	$	660.6
Gross profit	305.6			282.1			312.8		345.0
Net income (loss) (2)	(5.4		)	(16.8		)	11.3		28.2
Diluted net income (loss) per common share	$	(0.02	)	$	(0.06	)	$	0.04	$	0.10

(1) Net income in the first quarter of fiscal 2015 included restructuring charges of $8.0 million and a debt extinguishment loss of $6.7 million. Net income in the third quarter of fiscal 2015 included restructuring and divestiture charges of $11.9 million and a debt extinguishment loss of $18.2 million. Net income in the fourth quarter of fiscal 2015 included restructuring charges of $6.5 million, a debt extinguishment loss of $37.8 million, and an other-than-temporary impairment charge of $7.8 million related to a marketable security.

(2) Net loss in the first quarter of fiscal 2014 included restructuring charges of $18.4 million and a debt extinguishment loss of $2.9 million. Net loss in the second quarter of fiscal 2014 included an impairment charge related to the MRI breast coils product line of $28.6 million, restructuring charges of $11.6 million and a debt extinguishment loss of $4.4 million. Net income in the third quarter of fiscal 2014 included restructuring charges of $6.7 million. Net income in the fourth quarter of fiscal 2014 included restructuring and divestiture charges of $15.1 million and a $5.1 million IPR&D charge.